UPLC-Q-TOF/MS-Based Serum Metabolomics Reveals Potential Anti-tumor Mechanism of Banxia Xiexin Decoction in Colorectal Cancer Mice

被引:0
|
作者
YUE Yinzi [1 ]
LI Mingxuan [2 ]
WANG Xiaohui [3 ]
QIN Yuanyuan [4 ]
WANG Yahui [5 ]
TAN Jinhua [3 ]
SU Lianlin [2 ]
YAN Shuai [5 ]
机构
[1] Department of General Surgery, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine
[2] School of Pharmacy, Nanjing University of Chinese Medicine
[3] Department of General Surgery,Bayinguoleng Mongolian Autonomous Prefecture People's Hospital
[4] Department of Pharmacy, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine
[5] Department of Anorectal Surgery, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese
关键词
D O I
暂无
中图分类号
R285 [中药药理学];
学科分类号
摘要
Objective: To clarify the potential mechanism of Banxia Xiexin Decoction(BXD) on colorectal cancer(CRC) from the perspective of metabolomics. Methods: Forty male C57BL/6 mice were randomly divided into normal control(NC), azoxymethane/dextran sulfate sodium(AOM/DSS) model, low-dose BXD(L-BXD), high-dose BXD(H-BXD) and mesalamine(MS) groups according to a random number table, 8 mice in each group. Colorectal cancer model was induced by AOM/DSS. BXD was administered daily at doses of 3.915(L-BXD) and 15.66 g/kg(H-BXD) by gavage for consecutive 21 days, and 100 mg/kg MS was used as positive control. Following the entire modeling cycle, colon length of mice was measured and quantity of colorectal tumors were counted. The spleen and thymus index were determined by calculating the spleen/thymus weight to body weight. Inflammatory cytokine and changes of serum metabolites were analyzed by enzyme-linked immunosorbent assay kits and ultra performance liquid chromatography-quadrupole/time-of-flight mass spectrometry(UPLC-Q/TOF-MS), respectively. Results: Notably, BXD supplementation protected against weight loss, mitigated tumor formation, and diminished histologic damage in mice treated with AOM/DSS(P<0.05 or P<0.01). Moreover, BXD suppressed expression of serum inflammatory enzymes, and improved the spleen and thymus index(P<0.05). Compared with the normal group, 102 kinds of differential metabolites were screened in the AOM/DSS group, including 48 potential biomarkers, involving 18 main metabolic pathways. Totally 18 potential biomarkers related to CRC were identified, and the anti-CRC mechanism of BXD was closely related to D-glutamine and D-glutamate metabolism, phenylalanine, tyrosine and tryptophan biosynthesis, arginine biosynthesis, nitrogen metabolism and so on. Conclusion: BXD exerts partial protective effects on AOM/DSS-induced CRC by reducing inflammation, protecting organism immunity ability, and regulating amino acid metabolism.
引用
收藏
页码:623 / 632
页数:10
相关论文
共 50 条
  • [41] Untargeted metabolomics analysis based on HS-SPME-GC-MS and UPLC-Q-TOF/MS reveals the contribution of stem to the flavor of Cyclocarya paliurus herbal extract
    Liang, Lu
    Liu, Yuchen
    Liu, Yuxin
    Gan, Siyi
    Mao, Xuejin
    Wang, Yuanxing
    LWT-FOOD SCIENCE AND TECHNOLOGY, 2022, 167
  • [42] Anti-melanoma activity of Forsythiae Fructus aqueous extract in mice involves regulation of glycerophospholipid metabolisms by UPLC/Q-TOF MS-based metabolomics study
    Jiaolin Bao
    Fang Liu
    Chao Zhang
    Kai Wang
    Xuejing Jia
    Xiaotong Wang
    Meiwan Chen
    Peng Li
    Huanxing Su
    Yitao Wang
    Jian-Bo Wan
    Chengwei He
    Scientific Reports, 6
  • [43] Effects of Platycodins Folium on Depression in Mice Based on a UPLC-Q/TOF-MS Serum Assay and Hippocampus Metabolomics
    Wang, Cuizhu
    Lin, Hongqiang
    Yang, Na
    Wang, Han
    Zhao, Yan
    Li, Pingya
    Liu, Jinping
    Wang, Fang
    MOLECULES, 2019, 24 (09):
  • [44] UHPLC-Q-TOF/MS-Based Metabolomics Approach Reveals the Antifungal Potential of Pinocembroside against Citrus Green Mold Phytopathogen
    Chen, Chuying
    Cai, Nan
    Chen, Jinyin
    Wan, Chunpeng
    PLANTS-BASEL, 2020, 9 (01):
  • [45] UPLC-MS-Based Serum Metabolomics Reveals Potential Biomarkers of Ang II-Induced Hypertension in Mice
    Yang, Shaying
    Wang, Zhiwei
    Guo, Mengting
    Du, Mengfan
    Wen, Xin
    Geng, Li
    Yu, Fan
    Liu, Liangliang
    Li, Yanting
    Feng, Lei
    Zhou, Tingting
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [46] 16S rRNA and Metagenomics Combined with UPLC-Q/TOF-MS Metabolomics Analysis Reveals the Potential Mechanism of Radix Astragali Against Hyperuricemia in Mice
    Deng, Song
    Cai, Kaiwei
    Pei, Chaoying
    Zhang, Xingyuan
    Xiao, Xiaoyi
    Chen, Ye
    Chen, Ying
    Liang, Rongyao
    Chen, Yanlong
    Li, Pei
    Xie, Zhiyong
    Liao, Qiongfeng
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2023, 17 : 1371 - 1386
  • [47] Interpretation of Euphorbia Kansui Stir-Fried with Vinegar Treating Malignant Ascites by a UPLC-Q-TOF/MS Based Rat Serum and Urine Metabolomics Strategy Coupled with Network Pharmacology
    Zhang, Yi
    Gao, Jing
    Zhang, Qiao
    Wang, Kan
    Yao, Weifeng
    Bao, Beihua
    Zhang, Li
    Tang, Yuping
    MOLECULES, 2018, 23 (12):
  • [48] A UHPLC-Q-TOF-MS-based serum and urine metabolomics approach reveals the mechanism of Gualou-Xiebai herb pair intervention against atherosclerosis process in ApoE-/- mice
    Wang, Yuting
    Sun, Xin
    Qiu, Jingwen
    Zhou, An
    Xu, Pengbo
    Liu, Yarong
    Wu, Hongfei
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2023, 1215
  • [49] UPLC-Q/TOF-MS-Based Serum Metabolomics Reveals Hypoglycemic Effects of Rehmannia glutinosa, Coptis chinensis and Their Combination on High-Fat-Diet-Induced Diabetes in KK-Ay Mice
    Qin, Zhenxian
    Wang, Wei
    Liao, Dengqun
    Wu, Xiaoying
    Li, Xian'en
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (12)
  • [50] An integrated study on the comprehensive mechanism of Schisandra chinensis polysaccharides mitigating Alzheimer's disease in rats using a UPLC-Q-TOF-MS based serum and urine metabolomics strategy
    Fu, Jun
    Li, Jixun
    Sun, Yuzhen
    Liu, Shu
    Song, Fengrui
    Liu, Zhongying
    FOOD & FUNCTION, 2023, 14 (02) : 734 - 745